ASAndreza Maria Luzia Baldo de Souza

Andreza Maria Luzia Baldo de Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreza Maria Luzia Baldo de Souza has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Adesão a tratamento medicamentoso e terapias não farmacológicas no controle do diabetes mellitus tipo 2: uma revisão de escopo

    by Luis Francesquini Júnior, Enoque Fernandes de Araújo, Antonio Carlos Pereira, Andreza Maria Luzia Baldo de Souza

    Introdução: O Diabetes Mellitus tipo 2 (DM2) representa um dos principais desafios globais de saúde pública, exigindo estratégias terapêuticas contínuas que envolvam intervenções medicamentosas e não medicamentosas. A adesão ao tratamento é determinante para o controle glicêmico e a prevenção de complicações, mas ainda é comprometida por múltiplas barreiras. Objetivo: Mapear as evidências disponíveis sobre a adesão a tratamento medicamentoso e terapias não farmacológicas no controle do DM2, identificando fatores facilitadores, barreiras e lacunas de pesquisa. Métodos: Revisão de escopo conduzida com base nas diretrizes Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) e Joanna Briggs Institute, registrada no Open Science Framework. Foram incluídos estudos publicados entre 2014 e 2024 nas bases PubMed/Medical Literature Analysis and Retrieval System Online (MEDLINE), Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS) e ClinicalTrials.gov, nos idiomas português, espanhol e inglês. A busca combinou descritores relacionados a DM2, adesão, tratamento medicamentoso e terapias não farmacológicas. Foram considerados ensaios clínicos, estudos observacionais, revisões sistemáticas e coortes. A análise temática orientou a categorização dos resultados. Resultados: Foram incluídos 16 estudos. A síntese evidenciou 4 categorias principais: (I) barreiras à adesão, como polifarmácia, sintomas depressivos e resistência ao uso da insulina; (II) fatores facilitadores, como suporte social e estratégias de educação em saúde; (III) tecnologias digitais, como lembretes e aplicativos de autocuidado (relatados em menor número); e (IV) instrumentos de avaliação da adesão, como o Medication Adherence Test (MAT). Observou-se predominância de estudos brasileiros, ausência de padronização nos indicadores utilizados e escassez de investigações longitudinais. Conclusões: A adesão ao tratamento do DM2 continua sendo um fenômeno multifatorial, exigindo abordagens interdisciplinares. O uso de tecnologias pode ser promissor, mas ainda carece de validação e padronização. Intervenções baseadas em educação em saúde e apoio social demonstraram maior aplicabilidade. Futuras pesquisas devem explorar populações diversas e incluir indicadores consistentes, alinhando-se aos Objetivos de Desenvolvimento Sustentável (ODS), especialmente no que se refere ao acesso equitativo e à promoção do autocuidado

  • Open Access

    Analysis of hospitalizations and deaths due to stroke in different regions of Brazil before and during the COVID-19 pandemic

    by Andreza Maria Luzia Baldo de Souza, Antonio Carlos Pereira, Marcelo de Castro Meneghim

    Stroke, the second leading cause of death globally and a significant source of disability, has been impacted by the COVID-19 pandemic, which may increase the risks of cerebrovascular events. This observational and ecological time-series study sought to analyze hospitalizations and deaths due to stroke, covering the period from 2008 to 2022, using data from the Hospital Information System of the unified health system. The data were filtered by the code, which includes cerebrovascular accidents not specified as hemorrhagic or ischemic. The research resulted in a significant increase in hospitalization rates (R2=0.9437, p≤0.0001) and mortality (R2=0.8894, p≤0.0001) over the years. A drop was noted during the peak of the pandemic, followed by a rebound in the indices. The results indicate the urgency of reviewing and adapting public health strategies to prevent and treat stroke in post-pandemic Brazil, highlighting the increase in hospitalizations and deaths.

  • Open Access

    Análise das internações e óbitos por acidente vascular cerebral em diferentes regiões do Brasil antes e durante a pandemia de COVID-19

    by Andreza Maria Luzia Baldo de Souza, Antonio Carlos Pereira, Marcelo de Castro Meneghim

    Resumo O Acidente Vascular Cerebral, segunda maior causa de morte global e significativa fonte de incapacidade, viu-se impactado pela pandemia de COVID-19, que pode aumentar os riscos de eventos cerebrovasculares. Este estudo observacional e ecológico de série temporal buscou analisar as internações e óbitos por acidente vascular cerebral, cobrindo o período de 2008 a 2022, usando dados do Sistema de Informações Hospitalares do sistema único de saúde. Os dados foram filtrados pelo código, que contempla acidente vascular cerebral não especificados como hemorrágicos ou isquêmicos. A pesquisa resultou em um aumento significativo nas taxas de internação (R2=0,9437, p≤0,0001) e mortalidade (R2=0,8894, p≤0,0001) ao longo dos anos. Notou-se uma queda durante o pico da pandemia, seguida de uma recuperação nos índices. Os resultados indicam a urgência de revisar e adaptar estratégias de saúde pública para prevenir e tratar o acidente vascular cerebral no Brasil pós-pandemia, destacando o aumento de internações e mortes.

  • Open Access

    Estimativa de custos de tecnologias aplicadas no tratamento do Acidente Vascular Cerebral Isquêmico em hospital privado.

    by Andreza Maria Luzia Baldo de Souza, Antonio Carlos Pereira

    Ischemic stroke (IS) is one of the leading causes of mortality and disability in Brazil. This study aimed to estimate and compare the direct costs associated with the use of two advanced treatment technologies for IS—mechanical thrombectomy (MT) and intravenous thrombolysis (IVT)—in relation to conservative treatment (CT) in a private hospital. Using the bottom-up micro-costing method, we analyzed 146 cases of IS treated between 2020 and 2021. The costs assessed included emergency care, hospitalization, and in-hospital rehabilitation. Results showed that the mean cost per patient for mechanical thrombectomy (R$ 63,800.95) was significantly higher than for thrombolysis (R$ 13,861.11) and conservative treatment (R$ 11,976.94). Although mechanical thrombectomy requires a higher initial investment, its clinical benefits may justify the costs in the long term by reducing severe disabilities and the need for prolonged rehabilitation and support care. These findings provide concrete data to support decision-making regarding resource allocation for IS treatment in Brazil, emphasizing the importance of considering both immediate costs and potential economic savings due to improved patient outcomes.

  • Open Access

    Association between SARS-CoV-2 and stroke: perspectives from a metaumbrella-review

    by Andreza Maria Luzia Baldo de Souza, Enoque Fernandes de Araújo, Nelson Carvas Junior, Augusto Cesar Sousa Raimundo, Antonio Carlos Pereira, Marcelo de Castro Meneghim

    In the face of the global COVID-19 pandemic, the need arose to investigate potential complications associated with SARS-CoV-2, including the risk of stroke. Objective This study aimed to verify the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of stroke on the basis of systematic reviews and meta-analyses to assess the inclusion of the virus as a new risk factor for cerebrovascular diseases. Methods A metaumbrella study was conducted, which included 34 systematic reviews, of which 4 were selected for the final analysis on the basis of methodological quality and consistency. The analysis aggregated the results of 70 primary studies, considering different stroke subtypes and outcomes associated with COVID-19. Study heterogeneity was assessed via the I2 index, and significance bias was verified via Egger’s test. Results COVID-19 severity was significantly associated with an increased risk of stroke (eOR = 2.48; 95% CI: 1.55–3.95), particularly ischemic stroke (eOR = 1.76; 95% CI: 1.11–2.80) and hemorrhagic stroke (eOR = 3.86; 95% CI: 1.79–8.33). Additionally, patients with cerebrovascular comorbidities had higher mortality (eOR = 2.48; 95% CI: 2.48–19.63), as did those who had previously suffered a stroke (eOR = 6.08; 95% CI: 3.73–9.91). Conclusion The association between SARS-CoV-2 and stroke incidence was consistent and significant, suggesting that COVID-19 should be considered a new risk factor for cerebrovascular diseases. However, the high heterogeneity among the studies analyzed reinforces the need for further research to consolidate this relationship.


  • Open Access

    Financiamento, acesso e resolutividade da saúde pública em Minas Gerais

    by Cristiane dos Santos Paulino, Andreza Maria Luzia Baldo de Souza, Denise de Fátima Barros Cavalcante, Luciane Miranda Guerra, Júlia Vitório Octaviani, Brunna Verna de Castro Gondinho, Kyzze Correia Fontes, Maria Paula Maciel Rando Meirelles

    Introdução: Garantir a saúde como direito e dever do Estado, assegurada por políticas sociais e econômicas, persiste como desafio para o poder público, principalmente em relação ao seu financiamento.


  • Open Access

    Association between SARS-CoV-2 and Stroke: Perspectives from a metaumbrella-review

    by Andreza Maria Luzia Baldo de Souza, Enoque Fernandes de Araújo, Nelson Carvas, Augusto César Raimundo, Antonio Carlos Pereira, Marcelo de Castro Meneghim

    In the face of the global COVID-19 pandemic, the need arose to investigate potential complications associated with SARS-CoV-2, including the risk of Stroke. Objective: This study aimed to verify the association between SARS-CoV-2 and the risk of Stroke, based on systematic reviews and meta-analyses, in order to assess the inclusion of the virus as a new risk factor for cerebrovascular diseases. Methods: A metaumbrella was conducted, which included 34 systematic reviews, of which 4 were selected for the final analysis based on methodological quality and consistency. The analysis aggregated the results of 70 primary studies, considering different stroke subtypes and outcomes associated with COVID-19. Study heterogeneity was assessed using the I2 index, and significance bias was verified using Egger's test. Results: The analysis showed that the severity of COVID-19 is significantly associated with an increased risk of stroke (eOR = 2.48; 95%CI: 1.55 - 3.95), particularly for ischemic stroke (eOR = 1.76; 95%CI: 1.11 - 2.80) and hemorrhagic stroke (eOR = 3.86; 95%CI: 1.79 - 8.33). Additionally, patients with cerebrovascular comorbidities had higher mortality (eOR = 2.48; 95%CI: 2.48 - 19.63), as did those who had previously suffered a stroke (eOR = 6.08; 95%CI: 3.73 - 9.91). Conclusion: The association between SARS-CoV-2 and stroke was consistent and significant, suggesting that COVID-19 should be considered a new risk factor for cerebrovascular diseases. However, the high heterogeneity among the studies analyzed reinforces the need for further research to consolidate this relationship.

  • Open Access

    Análise das internações e óbitos por Acidente Vascular Cerebral em diferentes regiões do Brasil antes e durante a Pandemia de COVID-19

    by Andreza Maria Luzia Baldo de Souza, Antonio Carlos Pereira, Marcelo de Castro Meneghim

    Considered the second leading cause of death worldwide, Stroke poses a significant public health issue, also responsible for a substantial disability burden, with COVID-19 potentially predisposing individuals to cerebrovascular complications. Objective: To analyze stroke admissions and deaths in different regions of Brazil, before and during the COVID-19 pandemic. Methodology: An observational ecological time series study utilizing secondary data from the Hospital Information Systems (SIH) of the Unified Health System's Informatics Department (DATASUS), covering 2008 to 2022. Criteria included ICD-10 Category: I64 as unspecified hemorrhagic or ischemic stroke, all Brazilian federal units, with data compiled for hospital morbidity (SIH/SUS), including admissions and deaths for both males and females. Results: Data analysis showed a significant increase in admission cases (R2= 0.9437, p=<0.0001) and deaths (R2=0.8894, p=<0.0001) from 2008 to 2022. Conclusion: The study highlights the continued rise in stroke admissions and deaths in Brazil, with a pause during the pandemic's peak period, followed by a return to growth. These findings serve as a warning for public health managers to reassess and adapt stroke prevention and care strategies in the post-pandemic context.